Enrolling Clinical Trials

  1. Home
  2. Clinical Research
  3. Enrolling Clinical Trials

Clinical Trials

Below, are descriptions of clinical trials in which we are currently participating or have recently participated at Southeastern Retina Associates’ three East Tennessee main locations. More information on clinical trials is available at clinicaltrials.gov.

To ask about trials currently enrolling and the requirements to take part, patients or referring physicians may call any of research locations listed below.

Knoxville Based Clinical Trials

Clinical Site Location:
Tennessee Valley Eye Center
140 Capital Dr., Suite 2A
Knoxville, TN 37922

CT Main Number: 865-934-3866

  • Wet Macular Degeneration
    Study: Roche-Genentech Burgundy
    Learn More

    Study: DRCR Protocol AO (Treatment Naïve)
    Learn More

    Study: EyeBio/Merck
    Learn More

    Diabetic Retinopathy
    Study: DRCR Protocol AF (Non-Proliferative DR: Mild to Moderately Severe)
    Learn More

    Study: DRCR Protocol AFA (Various levels of DR)
    Learn More

    Macular Telangiectasia Type 2
    Study: LMRI “NHOR”
    Learn More

    Diabetic Macular Edema
    Study: EyeBio “BRUNELLO”
    Learn More

  • Geographic Atrophy
    Study: Gyroscope "Oracle”

    Diabetic Retinopathy
    Study: Genentech “Pavilion”
    Study: GLOW2 (Non-Proliferative DR: Moderately Severe to Severe)

Chattanooga Based Clinical Trials

1961 Northpoint Blvd
Suite 110
Hixson, TN 37343

CT Main Number: 423-756-1002

  • Wet Macular Degeneration
    Study: AbbVie “Ascent”
    Learn More

    Diabetic Macular Edema
    Study: EyeBio "Brunello"
    Learn More

    Choroidal Melanoma
    Study: Aura Biosciences "AU-011-301"
    Learn More

  • Diabetic Retinopathy
    Study: Novo Nordisk A/C “FOCUS”

Tri Cities Based Clinical Trials

Clinical Site Location:
161 Technology Lane
Johnson City, TN 37604

CT Main Number: 423-578-4364

  • Wet Macular Degeneration
    Study: AbbVie “Ascent”
    Learn More

  • RegenxBio
    Study: Ascent – Gene Therapy for Wet AMD

    Ocular Therapeutix
    Study: SOL-R – Tyrosine Kinase inhibitor implant for Wet AMD

    Annexon
    Study: ARCHER II – C1q complement inhibitor for Advanced Dry AMD/Geographic Atrophy

    Astellas
    Study: Reveal – Observational Study of Advanced Dry AMD/Geographic Atrophy patients receiving Izervay

    Eyebio
    Study: Barolo – Wnt agonist treatment for Diabetic Macular Edema